Chemical compound
Pharmaceutical compound
Etilevodopa (developmental code name TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson’s disease.[1] It is the ethyl ester of levodopa. It was never marketed.
See also
References
- ^ Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E (November–December 2003). “Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson’s disease: an open-label, randomized, crossover study”. Clinical Neuropharmacology. 26 (6): 322–6. doi:10.1097/00002826-200311000-00012. PMID 14646613. S2CID 23992241.
| Dopaminergics |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Anticholinergics | |||||||||||
| Others |
| ||||||||||
| |||||||||||
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||